TriplePoint Venture Growth BDC Corp.
TriplePoint Venture Growth BDC Corp. Announces
Third Quarter 2026 Financial Results
Source
From SEC EDGAR
119 releases originally issued via SEC EDGAR. The issuing organizations are responsible for their content.
Evommune, Inc.
Evommune Enters into Agreement to In-License EVO570, a Potential Best-in-Class Oral VAV1 Molecular Glue Degrader, from Hinova Pharmaceuticals
Oral, highly selective and potent VAV1 molecular glue degrader designed to deliver a differentiated clinical profile across a broad range of…
Granite Point Mortgage Trust Inc.
Granite Point Mortgage Trust Inc. Reports
Third Quarter 2026 Financial Results
Compass Diversified Holdings
Compass Diversified Holdings
Compass Diversified Reports Third Quarter 2026 Financial Results
Silvaco Group, Inc.
Silvaco Reports Third Quarter 2026 Financial Results
Won major new tier-1 FTCO customer and 4 tier-1 customers for Jivaro Pro in Q3
Sera Prognostics, Inc.
PreTRM® test volume increases 54% sequentially and approximately five-fold from 1Q26
Ordering healthcare providers increase 34% sequentially and approximately three-fold from 1Q26
CF Industries Holdings, Inc.
CF Industries Holdings, Inc.
CF Industries Holdings, Inc. Reports First Nine Months 2026 Net Earnings of $1.78 Billion, Adjusted EBITDA of $3.01 Billion
American Homes 4 Rent, L.P.
American Homes 4 Rent, L.P.
AMH Reports Third Quarter 2026 Financial and Operating Results
Dianthus Therapeutics, Inc. /DE/
Advancing a neuromuscular franchise with claseprubart, a highly potent, investigational classical pathway inhibitor, with best-in-disease potential across generalized Myasthenia Gravis (gMG), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), and Multifocal Motor Neuropathy (MMN)
Phase 3 EMERGE registrational trial of claseprubart in gMG evaluating 300mg/2mL Q2W and 300mg/2mL Q4W on track, with top-line results expected in…
Park Ohio Holdings Corp
ParkOhio Announces Record Sales and Strong Third Quarter 2026 Results;
Raises FY 2026 Sales and Adjusted EPS Outlook on Continued Strong Demand Across Its Diversified End Markets
HMH Holding Inc
HMH Holding Inc. Announces Third Quarter 2026 Results
Arcutis Biotherapeutics, Inc.
Arcutis Announces Third Quarter 2026 Financial Results and Provides Business Update
Outset Medical, Inc.
Outset Medical Reports Third Quarter 2026 Results
TrueBlue, Inc.